Saturday 17 October 2026
Export BRKR’s income statement to Excel — free account
Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.
54.80
1.74
−3.08%
Follow BRKR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 77.13 | 24.76 | 34.54 | 45.85 | 52.55 | 39.82 | 25.89 | 69.04 | 22.72 |
Piotroski F-Score |
4 | 3 | 6 | 5 | 8 | 5 | 6 | 7 | 7 | 7 |
Altman Z-Score |
2.43 | 2.77 | 4.33 | 4.69 | 5.15 | 4.41 | 4.81 | 4.70 | 5.15 | 4.25 |
P/S ratio |
2.08 | 2.59 | 3.57 | 4.06 | 5.25 | 4.18 | 3.82 | 2.45 | 3.09 | 2.16 |
P/FCF ratio |
105.01 | 54.32 | 39.50 | 55.81 | 57.72 | 31.94 | 44.90 | 21.56 | 37.13 | 29.12 |
Altman Z″-Score (non-manufacturers) |
2.98 | 2.99 | 4.47 | 5.20 | 5.44 | 4.98 | 5.47 | 5.47 | 5.78 | 5.65 |
Beneish M-Score |
(2.56) | (2.28) | (2.23) | (2.20) | (2.38) | (2.79) | (2.60) | (2.26) | (2.37) | (2.41) |
P/Operating CF |
31.12 | 45.97 | 51.51 | 59.85 | 91.66 | 40.90 | 58.08 | 35.15 | 52.63 | 38.36 |
Dividend Safety Score |
34 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.89 | 4.86 | 7.59 | 9.12 | 11.71 | 8.52 | 8.63 | 5.14 | 7.44 | 5.03 |
Price to Tangible BV |
272.95 | 0.00 | 21.98 | 25.84 | 23.82 | 19.55 | 20.24 | 11.32 | 11.34 | 7.07 |
EV/Sales |
2.54 | 3.16 | 3.84 | 4.28 | 5.32 | 4.23 | 3.88 | 2.46 | 3.08 | 2.11 |
EV/EBITDA |
30.23 | 24.37 | 20.62 | 20.78 | 25.62 | 25.60 | 21.35 | 14.26 | 19.17 | 14.38 |
EV/Operating CF |
65.04 | 42.36 | 32.50 | 39.50 | 45.57 | 25.33 | 37.67 | 19.48 | 35.20 | 25.95 |
EV/FCF |
128.07 | 66.20 | 42.45 | 58.93 | 58.47 | 32.37 | 45.62 | 21.64 | 36.97 | 28.38 |
Quick Ratio |
0.66 | 0.58 | 0.82 | 1.22 | 1.69 | 1.35 | 1.62 | 1.13 | 1.45 | 1.42 |
Current Ratio |
1.73 | 1.60 | 1.80 | 2.31 | 2.63 | 2.43 | 2.78 | 2.18 | 2.59 | 2.43 |
Net Debt/EBITDA |
5.44 | 4.37 | 1.44 | 1.10 | 0.33 | 0.34 | 0.34 | 0.06 | (0.08) | (0.38) |
Debt/Assets |
29.95% | 36.07% | 30.15% | 33.76% | 36.55% | 27.70% | 29.35% | 16.02% | 21.33% | 22.77% |
Debt/Equity |
0.76 | 1.17 | 0.92 | 1.08 | 1.23 | 0.87 | 0.89 | 0.38 | 0.57 | 0.59 |
Asset Turnover |
0.57 | 0.67 | 0.75 | 0.70 | 0.72 | 0.68 | 0.85 | 0.93 | 0.94 | 0.91 |
Operating CF/Net income |
(5.96) | 2.22 | 0.82 | 0.93 | 1.02 | 2.11 | 1.08 | 1.33 | 1.96 | 0.85 |
Capex/Depreciation |
(0.41) | (0.63) | (0.93) | (1.30) | (0.98) | (1.21) | (0.82) | (0.75) | (0.50) | (0.66) |
| (1.05%) | 7.09% | 33.90% | 26.84% | 26.92% | 16.69% | 21.64% | 21.93% | 11.02% | 21.54% | |
| (0.37%) | 2.25% | 10.87% | 8.17% | 8.27% | 5.42% | 8.05% | 8.82% | 4.18% | 8.68% | |
ROIC |
1.05% | 4.27% | 12.48% | 15.91% | 20.66% | 14.28% | 17.99% | 17.75% | 19.32% | 18.80% |
Return on Tangible Assets |
(1.34%) | 7.85% | 27.35% | 17.59% | 14.29% | 10.32% | 13.54% | 18.42% | 7.14% | 15.51% |
Average Days of Receivables |
57.88 | 61.31 | 60.58 | 68.18 | 62.93 | 61.58 | 63.79 | 68.78 | 66.00 | 55.25 |
Research and Development Expense of Revenue |
11.50% | 11.18% | 9.94% | 9.32% | 9.13% | 9.96% | 9.06% | 9.15% | 9.15% | 9.18% |
Selling, General and Administrative Expense of Revenue |
27.54% | 26.55% | 24.60% | 24.00% | 23.21% | 23.58% | 24.13% | 23.46% | 23.51% | 24.19% |
Intangible Assets out of Total Assets |
0.39 | 0.42 | 0.21 | 0.20 | 0.15 | 0.18 | 0.19 | 0.23 | 0.13 | 0.11 |
Share Based Compensation of Revenue |
0.59% | 0.75% | 1.04% | 1.09% | 0.71% | 0.81% | 0.46% | 0.60% | 0.62% | 0.58% |
Graham Net Nets |
(0.22) | (0.22) | (0.07) | (0.04) | (0.01) | (0.02) | (0.01) | 0.02 | 0.03 | 0.05 |
Graham Number |
0.00 | 14.36 | 25.02 | 18.46 | 17.17 | 12.13 | 13.05 | 12.24 | 7.22 | 9.58 |
Earnings Yield |
(0.32%) | 1.30% | 4.04% | 2.90% | 2.18% | 1.90% | 2.51% | 3.86% | 1.45% | 4.40% |
Free Cash Flow Yield |
0.95% | 1.84% | 2.53% | 1.79% | 1.73% | 3.13% | 2.23% | 4.64% | 2.69% | 3.43% |
Revenue per Share |
22.64 | 22.59 | 20.25 | 17.03 | 15.97 | 12.96 | 13.35 | 12.14 | 11.17 | 9.98 |
Operating CF per Share |
0.88 | 1.69 | 2.39 | 1.85 | 1.87 | 2.17 | 1.38 | 1.53 | 0.98 | 0.81 |
Capex per Share |
(0.60) | (0.77) | (0.73) | (0.78) | (0.58) | (0.63) | (0.40) | (0.31) | (0.20) | (0.22) |
Free Cash Flow per Share |
0.29 | 0.91 | 1.66 | 1.07 | 1.29 | 1.53 | 0.98 | 1.22 | 0.77 | 0.59 |
Cash per Share |
1.97 | 1.23 | 3.34 | 4.34 | 7.72 | 4.77 | 4.41 | 2.06 | 2.78 | 3.10 |
Shareholders Equity per Share |
16.29 | 12.06 | 9.53 | 7.58 | 7.16 | 6.35 | 5.91 | 5.79 | 4.64 | 4.29 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
16.29 | 12.06 | 9.53 | 7.58 | 7.16 | 6.35 | 5.91 | 5.79 | 4.64 | 4.29 |
Free Cash Flow |
43.30 | 136.00 | 243.20 | 159.10 | 195.30 | 235.20 | 151.40 | 190.90 | 122.20 | 94.80 |
Working Capital |
933.30 | 771.90 | 962.10 | 1,198.90 | 1,533.30 | 1,133.10 | 1,150.70 | 705.00 | 834.30 | 751.20 |
Capital Expenditures |
(90.80) | (115.30) | (106.90) | (115.30) | (87.10) | (97.00) | (62.00) | (48.80) | (32.20) | (36.00) |
Net Current Asset Value |
(1,555.40) | (1,956.40) | (691.10) | (372.90) | (93.60) | (149.70) | (58.10) | 80.80 | 143.80 | 160.60 |
EV/EBIT |
127.88 | 42.06 | 26.04 | 25.05 | 31.14 | 33.90 | 26.72 | 17.79 | 24.76 | 18.67 |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.05 | 0.04 | 0.05 | 0.03 | 0.03 | 0.02 | 0.02 |
Price to Operating Income |
104.86 | 34.51 | 24.23 | 23.72 | 30.74 | 33.44 | 26.29 | 17.72 | 24.86 | 19.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.27 | 0.19 | 0.18 | 0.22 | 0.20 | 0.25 | 0.24 | 0.24 | 0.23 |
Cash ROIC |
0.93% | 3.34% | 7.69% | 5.32% | 5.44% | 9.22% | 6.27% | 12.17% | 7.69% | 5.91% |
Accounts Receivable Turnover |
6.19 | 6.37 | 6.15 | 5.69 | 6.43 | 5.70 | 5.76 | 5.60 | 6.27 | 6.73 |
Accounts Payable Turnover |
8.26 | 7.86 | 7.62 | 7.52 | 8.57 | 8.28 | 9.67 | 10.20 | 10.74 | 10.95 |
Inventory Turnover |
1.72 | 1.69 | 1.64 | 1.62 | 1.72 | 1.65 | 1.98 | 2.00 | 2.05 | 2.01 |
Average Days of Payables |
42.39 | 49.77 | 50.98 | 53.16 | 44.53 | 46.89 | 40.12 | 38.31 | 34.89 | 36.29 |
Days of Inventory on Hand |
214.94 | 227.01 | 243.54 | 238.40 | 214.51 | 241.19 | 195.56 | 186.83 | 186.82 | 185.62 |
Average Receivables |
555.20 | 528.75 | 482.35 | 444.80 | 376.10 | 348.75 | 359.70 | 338.25 | 281.60 | 239.30 |
Average Payables |
225.00 | 218.40 | 190.55 | 162.90 | 141.00 | 126.50 | 111.45 | 97.65 | 88.45 | 79.10 |
Average Inventory |
1,081.20 | 1,018.05 | 884.20 | 755.10 | 701.20 | 634.75 | 543.40 | 497.90 | 463.30 | 431.20 |
Average Assets |
6,024.05 | 5,028.30 | 3,930.85 | 3,630.90 | 3,349.50 | 2,910.25 | 2,450.05 | 2,038.55 | 1,878.45 | 1,769.20 |
Average Common Equity |
2,135.30 | 1,595.85 | 1,260.15 | 1,105.15 | 1,029.45 | 945.70 | 911.10 | 819.30 | 713.30 | 713.00 |
Columns are period end dates